Clinical trial policy is shifting research closer to patients, creating new demands for forecasting, distribution, inventory, accountability, cold chain, and cross-functional planning.
- Why Shelf Life Should Shape Global Country Activation
- Three Months Too Late: How Late Decisions Create Clinical Supply Challenges
- The Hidden Work Between Protocol And Execution: Translating Requirements Into Supply Strategy
- Clinical Trial Supply In The EU And U.K.: A Regulatory Guide
- Clinical Supply Chains Need To Solve Problems Before They Happen
- How New Models Could Improve Trial Enrollment Forecasts
- Can Site Enrollment Data Improve Clinical Trial Forecasts?
- Can Standardizing Protocols Improve Clinical Supply Execution?
ON-DEMAND WEBINARS
Decentralized clinical trials are made up of a multitude of elements, from in home clinical capabilities, logistics, digital platforms, and technology, to global reach and more. This webinar shares important factors to consider to build your DCT ‘molecule’ successfully.
Gain essential insights into QP roles, regulatory updates, and best practices for ensuring compliance, supply continuity, and safe handling of cold and frozen pharmaceutical products across the UK and EU.
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
This webinar brings together a panel of supply chain experts to bring insight into managing the uncertainty and risk that comes along with clinical supply decisions.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1346675584-team-lab-research-development]( "Key Considerations For Emerging Companies When Selecting Packaging Components")
Key Considerations For Emerging Companies When Selecting Packaging ComponentsRecognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.
-
![iStock-1293772969-lab-microscope-scientist-research]( "Clinical Manufacturing: What It Is And How It Works")
Clinical Manufacturing: What It Is And How It WorksClinical manufacturing is a specialized form of pharmaceutical manufacturing focused on producing drugs for clinical research. How does it work and how is it different from commercial manufacturing?
-
![Ampoule Aseptic Filling GettyImages-1490244818]( "Advantages Of Robotic Aseptic Processing")
Advantages Of Robotic Aseptic ProcessingExamine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Outgrowing Excel: Implementing RTSM In A Live Phase I Trial")
Outgrowing Excel: Implementing RTSM In A Live Phase I TrialLearn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
-
![Pharma Manufacturing GettyImages-1135140594]( "Outsourcing Your Highly Potent Oncology Drug Product")
Outsourcing Your Highly Potent Oncology Drug ProductPrecision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.
-
![4_PharmaSource_Conference_CDMO Live copy]( "The Phase 2 Manufacturing Wall: The CMC Risk Hiding In Plain Sight")
The Phase 2 Manufacturing Wall: The CMC Risk Hiding In Plain SightHidden gaps in process maturity and organizational alignment can derail development. Discover how to identify risks early and improve readiness for key milestones.
-
![West]( "Vial Containment Systems For Gene And Cell Therapies")
Vial Containment Systems For Gene And Cell TherapiesCZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.
-
![iStock-1276580570-cryopreservation]( "Key Considerations For Labeling Your Cell Or Gene Therapy")
Key Considerations For Labeling Your Cell Or Gene TherapyAs sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.
-
![West Pharma]( "Key Considerations For Packaging Solutions For Cell And Gene Therapies")
Key Considerations For Packaging Solutions For Cell And Gene TherapiesThinking of packaging and delivery factors early and often will minimize risks to the safety and efficacy of your cell and gene therapy drug product from the bench to the patient.
-
![Getty-1652511983-supply-chain-management]( "Increasing Efficiency And Reducing Drug Waste")
Increasing Efficiency And Reducing Drug WasteDiscover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.
BEYOND THE HEADLINES
What happened. What it means for clinical supply.
-
![Blank medicine bottle-GettyImages-172796313]( "Kerala's Trial-Labeled SMA Medicine Raises Questions About Inventory Controls")
Medicine labeled for clinical trials reached children receiving routine SMA treatment in Kerala, raising questions about inventory controls, labeling and supply authorization.
-
![scientists, research, laboratory meeting-GettyImages-2284596589]( "Syneos Health And Optum Target Clinical Trial Planning With New Partnership")
Syneos Health and Optum are developing adaptive clinical trial planning capabilities that could help sponsors anticipate protocol changes and supply risks earlier.
-
![Black female doctor reviews medical record-GettyImages-2231130594]( "AstraZeneca And Oracle Explore AI To Improve Clinical Trial Recruitment")
AstraZeneca and Oracle are exploring AI for clinical trial recruitment, raising questions about how earlier enrollment insights could shape clinical supply forecasting and resupply plans.
-
![science laboratory research, healthcare innovation, development, investigation-GettyImages-1751659695]( "Filament Health To Supply Psilocybin For Proposed Belgian Compassionate Use Program")
Filament Health will supply psilocybin for a proposed Belgian compassionate use program, pending regulatory approval and required authorizations for cross-border supply.
-
![medical lab technicians Working Together-GettyImages-2187044930]( "Prelude Therapeutics And Lilly Agree To Supply Drugs For Combination Trial")
Prelude Therapeutics and Lilly agree to supply two medicines for a Phase 1 breast cancer trial, highlighting coordination needs as the study advances to combination cohorts.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
